Trade

Beta Drugs share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • ₹1,073.90(-2.19%)
    March 9, 2026 15:40:51 PM IST
    • NSE
    • BSE
  • Vol : 7.43 K (NSE + BSE)
    Last 20 day avg : 19.15 K

Beta Drugs is trading -2.19% lower at Rs 1,073.90 as compared to its last closing price. Beta Drugs has been trading in the price range of 1,129.00 & 1,061.00. Beta Drugs has given -29.12% in this year & 4.95% in the last 5 days. Listed peers of Beta Drugs include Torrent Pharmaceuticals (1.67%), Divi's Laboratories (0.40%), Cipla (-0.13%).The Mutual Fund holding in Beta Drugs was at -% in . The MF holding has - from the last quarter. The FII holding in Beta Drugs was at 1.14% in 31 Dec 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Mar 09, 2026, 06:57 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.02
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.70
    Higher than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
1,061.00
Highest
1,129.00
52 week range
Lowest
990.10
Highest
2,000.00
Beta Drugs News
Beta Drugs Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Torrent Pharmaceuticals
Bullish
4,380.001.671,47,982.3967.3217.10.8317.62
Divi's Laboratories
Neutral
6,352.850.401,70,706.6678.6111.520.460.01
Cipla
Bearish
1,320.00-0.131,06,627.0522.953.870.870.81
Sun Pharmaceutical Industries
Bullish
1,807.600.484,34,647.9336.245.770.920.50
Dr Reddy's Laboratories
Neutral
1,283.50-1.561,07,047.5318.633.140.632.34
Beta Drugs Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-14Quarterly Results
2026-01-09Others
2025-11-06Quarterly Results
2025-05-15Audited Results
2025-03-27Others
About the company Beta Drugs
  • IndustryBiotechnology & Drugs
  • ISININE351Y01019
  • BSE Code
  • NSE CodeBETA
Beta Drugs Limited is an India-based oncology medicine manufacturing company. The Company specializes in the intricate field of complex chemical synthesis for anti-cancer bulk drugs and finished dosages. The Company operates through one segment, Pharmaceuticals. Its product category includes cosmeceutical products and oncology products. The cosmeceutical products include La’Thrix, BACINOX, URTICALM, HUMIDA, NUSPLASH, UVIREX, ADVIBE, SENSIBAR, and RECAPRO. The oncology products include Temozad(Temozolomide), ADVIN(Vinorelbine), ADSIDE(Etoposide), ADRIB(Doxorubicin), ADCOV(Leucovorin calcium), ADPLATIN(Oxaliplatin), INOTAD(Irinotecan), ADCIST(Cisplatin), ADCARB(Carboplatin), ERLOTAD(Erlotinib), ADOXI(Docetaxel), AMGICIN(Gemcitabine), ADPAXIL(Paclitaxel), ADMIDE(Bicalutamide), and others. The Company's subsidiaries include Adley Lab Limited and Adley Formulations Private Limited.
  • Management Info
  • Vijay BatraChairman of the Board, Managing Director
  • Jayant KumarChief Financial Officer
  • Rajni BrarCompliance Officer, Company Secretary
  • Neeraj BatraWhole Time Director
  • Rahul BatraWhole Time Director
  • Varun BatraWhole Time Director
  • Balwant SinghWhole Time Director
Beta Drugs Share Price FAQs

Beta Drugs is trading at 1073.90 as on Mon Mar 09 2026 10:10:51. This is -2.19% lower as compared to its previous closing price of 1098.00.

The market capitalization of Beta Drugs is 1088.60 Cr as on Mon Mar 09 2026 10:10:51.

The 52 wk high for Beta Drugs is 2000.00 whereas the 52 wk low is 990.10

Beta Drugs can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 23.53
  • Dividend Yield: %
  • D/E ratio: -

Beta Drugs reported a net profit of 42.42 Cr in 2025.

Quick Links
EQUITY QUICK LINKS
Beta Drugs QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Beta Drugs share price